SCHEMBL25523327

SCHEMBL25523327

Cc1ccc(CNCc2ncccc2F)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.41
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
HTR1A P08908 8/20 0.38
F2 P00734 2/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
CYP2C19 P33261 1/20 0.35
DYRK3 O43781 1/20 0.35
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK2 Q92630 1/20 0.35
DYRK4 Q9NR20 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25522223 0.85 SCN8A (0.39) ADORA2AMAOAMAOBHTR1ADYRK1B
SCHEMBL31064643 0.83 KDM1A (0.39) KDM1AMAOAMAOBKDM4EALDH1A1
SCHEMBL31064603 0.81 KDM1A (0.51) ADORA2AKDM1AMAOAMAOBDYRK3
SCHEMBL23758036 0.81 NPC1 (0.48) KDM1AMAOAMAOBF2KDM4E
SCHEMBL30025826 0.81 NPC1 (0.48) KDM1AMAOAMAOBF2KDM4E
SCHEMBL25207059 0.81 HTR1A (0.38) ADORA2AKDM1AMAOAMAOBHTR1A
SCHEMBL23757857 0.80 KDM1A (0.37) ADORA2AKDM1AMAOAMAOBF2
SCHEMBL25522228 0.79 TLR7 (0.41) ADORA2AHTR1AKDM4ENPC1RAB9A
SCHEMBL25225376 0.78 ALDH1A1 (0.43) ADORA2AKDM4ENPC1ALDH1A1RAB9A
SCHEMBL25523353 0.77 CXCR4 (0.41) ADORA2AHTR1AKDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159510-A1 NOVEL PRMT5 INHIBITORS AMGEN INC. (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159510-A1 NOVEL PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 ADORA2A 4422/4885KDM1A 41/4885MAOA 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.